Antimicrobial resistance of Escherichia coli and therapeutic implications
- 8 August 2005
- journal article
- review article
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 295 (6-7) , 503-511
- https://doi.org/10.1016/j.ijmm.2005.07.002
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Bacterial Persistence as a Phenotypic SwitchScience, 2004
- Noninherited Resistance to AntibioticsScience, 2004
- Extended Spectrum ??-Lactamase (ESBL)-Producing EnterobacteriaceaeDrugs, 2003
- Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000)Diagnostic Microbiology and Infectious Disease, 2002
- Clinical Course and the Role of Shiga Toxin–ProducingEscherichia coliInfection in the Hemolytic‐Uremic Syndrome in Pediatric Patients, 1997–2000, in Germany and Austria: A Prospective StudyThe Journal of Infectious Diseases, 2002
- Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998–99)Diagnostic Microbiology and Infectious Disease, 2002
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Laboratory detection of extended-spectrum β-lactamases (ESBLs)—The need for a reliable, reproducible methodDiagnostic Microbiology and Infectious Disease, 2000
- Control of a Prolonged Outbreak of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a University HospitalClinical Infectious Diseases, 1999
- Antibiotic Usage in AnimalsDrugs, 1999